beacon-intelligence.com
Open in
urlscan Pro
20.50.64.6
Public Scan
Submitted URL: https://info.hansonwade.com/e/448062/-utm-content-beacon-checkpoint/9zpfq1/1211712699?h=CXgdexHC1XNkjvEbiulCbAB12ABCDEFGHIJK...
Effective URL: https://beacon-intelligence.com/solutions/checkpoint/?utm_source=internal-beacon&utm_medium=email&utm_campaign=infographic&utm_c...
Submission: On August 27 via api from CH — Scanned from DE
Effective URL: https://beacon-intelligence.com/solutions/checkpoint/?utm_source=internal-beacon&utm_medium=email&utm_campaign=infographic&utm_c...
Submission: On August 27 via api from CH — Scanned from DE
Form analysis 3 forms found in the DOM
GET /
<form class="search-form" method="get" action="/">
<input type="text" name="s" placeholder="Search...">
</form>GET https://beacon-intelligence.com/
<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
<label for="search-form-6309dc8b9130c"></label>
<input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
<button type="submit" class="wpr_submit">
<i class="wpr-icon-search"></i>
</button>
</form>GET https://beacon-intelligence.com/
<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
<label for="search-form-6309dc8b93e8d"></label>
<input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
<button type="submit" class="wpr_submit">
<i class="wpr-icon-search"></i>
</button>
</form>Text Content
* Home * Solutions * Beacon ADC * Beacon Adoptive Cell * Beacon Bispecific * Beacon Cancer Vaccine * Beacon Checkpoint * Beacon Cytokine * Beacon DDR * Beacon Gene Therapy * Beacon Microbiome * Beacon RNA * Beacon Oncolytic Viruses * Beacon TPD * About * News * Events * Resources * Contact * Login MAKE FASTER AND BETTER INFORMED DRUG DEVELOPMENT DECISIONS The efficacy and safety profiles of PD-1/L-1 targeting antibodies has led to an unprecedented number of clinical trials starting, where combining with other modalities has become the norm. Several thousand monotherapy and combination trials are underway. The sheer size and complexity of the landscape means analysis is plagued by false positives. The rate at which this landscape is expanding and the complexity of trials means that sifting through false positives to create accurate results was inevitable until Beacon responded. Request a demoFind out more Home > Beacon Checkpoint BEACON CHECKPOINT BENEFIT FROM THE MOST COMPLETE CLINICAL TRIAL AND DRUG LANDSCAPE FOR IMMUNE CHECKPOINT MODULATORS WHAT WE COVER Beacon Checkpoint is a sector-specific curated database that includes trial and drug records for preclinical, active, approved, and discontinued: * Immune Checkpoint Modulator Combinations * Immune Checkpoint Modulators Monotherapies * Across over 27 different checkpoint targets HOW BEACON HELPS Here are a few example use cases that have benefitted our clients in accelerating their checkpoint development programs: * Benchmark drug development and clinical trial strategies against competitors. * Get an in-depth overview of the landscape and insights into your competitors’ preclinical and clinical assets. * Drastically reduce manual research time with our database solution which allows users to rapidly assemble data for analysis on, line of therapy, clinical trial arms, disease indication, and much more. * Identify new players and new assets entering the clinic and monitor their progress. * Real time updates to help you keep abreast of new players, clinical entries and data releases. HOW BEACON CHECKPOINT WORKS Use an intelligent search function to instantaneously sweep the clinical trial and drug landscapes using 20 search criteria including therapeutic class, target etc… Search for combinations in trials or individual arms to avoid false positives. Key data points are presented in the results page and can be easily downloaded into Excel to run more complex analyses. If publicly available, information regarding trials where an immune checkpoint is in combination with an antibody-drug conjugate, bispecific, cell therapy or gene therapy will also be included in our trial coverage. HOW WE SOURCE THE DATA FOR CHECKPOINT THERAPIES We house all publicly available sources of data updated with 24 – 48 hours of publication proactively. Our sources cover (but are not limited to): * Clinical trials registries * Scientific journals and publications * Company reports and presentations * Press releases * Conference reports and abstracts * Government and regulatory organizations * Newspapers and other media * Patents RELATED CONTENT CHECKPOINT: MID-YEAR LANDSCAPE REVIEW 2022 Find out more 4-1BB LANDSCAPE REVIEW: SHIFT TOWARDS A BISPECIFIC THERAPEUTICS APPROACH Find out more CHECKPOINT ASCO POST-CONFERENCE REPORT 2022 Find out more WHAT OUR CUSTOMERS SAY "I’VE RARELY SEEN SUCH DEDICATION FROM A SERVICE PROVIDER IN UNDERSTANDING AND RESPONDING TO OUR NEEDS" Competitive Intelligence Manager Top 20 Pharma OUR CHECKPOINT EXPERT AHMED TAJMOHAMED IS THE RESEARCH ANALYST FOR CHECKPOINT IN THE BEACON TARGETED THERAPIES TEAM. Sign up for our weekly newsletter with the latest Checkpoint landscape with data from Beacon Checkpoint. Subscribe to newsletter OTHER BEACON SOLUTIONS ADC Adoptive Cell Bispecific Cancer Vaccine Cytokine DDR Gene Therapy RNA Microbiome Oncolytic Viruses TPD Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more Find out more Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more Find out more Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more Find out more Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field. Find out more Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families. Find out more Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field. Find out more From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks. Find out more Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space. Find out more Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape. Find out more From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field. Find out more Beacon TPD provides the solution you need to master the targeted protein degradation field. Find out more ANY QUESTIONS? CONTACT US TO LEARN MORE ABOUT HOW WE CAN TAILOR BEACON CHECKPOINT TO HELP YOU, GET IN TOUCH WITH OUR SALES TEAM FRANK PLOWDEN Checkpoint Account Manager Contact the Team ABOUT BEACON TARGETED THERAPIES We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development. USEFUL LINKS * About * Contact * Events * FAQS * Resources * Solutions * Careers SOLUTIONS * Beacon Microbiome * Beacon Cytokine * Beacon TPD * Beacon Oncolytic Viruses * Beacon Checkpoint * Beacon Adoptive Cell * Beacon RNA * Beacon Cancer Vaccine * Beacon DDR * Beacon Gene Therapy * Beacon Bispecific * Beacon ADC LATEST CONTENT * RNA: Mid-Year Landscape Review * Checkpoint: Mid-Year Landscape Review 2022 * DDR: Mid-Year Landscape Review * Bispecific: Mid-Year Landscape Review 2022 * ADC: Mid-Year Landscape Review 2022 * Terms & Conditions * Site Map © 2022 TOAST DESIGN | Reg Office: 52 Grosvenor Gardens, London, SW1W 0AU. Beacon is a trading name of Hanson Wade Follow us on social media * * Home * Solutions * Beacon ADC * Beacon Adoptive Cell * Beacon Bispecific * Beacon Cancer Vaccine * Beacon Checkpoint * Beacon Cytokine * Beacon DDR * Beacon Gene Therapy * Beacon Microbiome * Beacon RNA * Beacon Oncolytic Viruses * Beacon TPD * About * News * Events * Resources * Contact * Login * * This is the brochure-popup This is the contact us popup Hover over page elements to highlight them, then click to create an annotation.